Motilal Oswal Nasdaq 100 Fund of Fund vs Edelweiss US Technology Equity Fund of Fund compare
Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
Chart Comparison
| Scheme Name | Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Fund | Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹5138 Cr | ₹2257 Cr |
| Min Investment | ₹500 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹500 | ₹100 |
| Launch Date | 29 Nov 2018 | 05 Mar 2020 |
| Category | International | International |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE India Bond Index | Russel 1000 Equal Weighted Technology |
| Turn Over | 11.16% | 18% |
| Expense Ratio | 0.58 | 2.36 |
| Manager | Rakesh Shetty | Bhavesh Jain |
| ISIN Code | INF247L01700 | INF754K01LC5 |
| Exits Load | Data not available./365 | Edelweiss US Technology Equity FOF - Growth charges 1.0% of sell value; if fund sold before 90 days. There are no other charges./365 |
| Scheme Name | Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| 1 Month | 2.53% | 8.41% |
| 6 Month | 39.1% | 41.56% |
| 1 Year | 46.67% | 37.39% |
| 3 Year | 23.82% | 20.2% |
| 5 Year | 25.06% | - |
| Scheme Name | Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 60.07% | 50.62% |
| 3 Year | 39.66% | 38.04% |
| 5 Year | 27.38% | - |
| Scheme Name | Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| 1 Year | 33.31% | 31.09% |
| 3 Year | 15.32% | 7.83% |
| 5 Year | 23.75% | - |
| Scheme Name | Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Standard Deviation | 21.14% | 27.68% |
| Sharp | 0.5% | 0.2% |
| Beta | - | - |
| Alpha | - | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Name | Rakesh Shetty | Bhavesh Jain |
| Total AUM | ₹33886 Cr | ₹0 Cr |
| Fund Manage | 19 | 22 |
| Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
| Scheme Name |
Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth |
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Others | 100 | 100 |
| Scheme Name |
Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth |
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Others | 0.53 | 0 |
| Unclassified | 99.47 | - |
| Financial | - | 100 |
Top Comparisons
ICICI Prudential Passive Multi-Asset Fund of Funds - Growth
3Y Returns11.72%
Kotak Multi Asset Allocator Fund of Fund - Dynamic - Growth
3Y Returns17.76%
Kotak Healthcare Fund - Regular (G)
3Y Returns0%
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
3Y Returns18.25%
BANDHAN Bond Fund - Short Term - Regular Plan - Growth
3Y Returns6.16%
Axis Short Duration Fund - Regular Plan - Growth Option
3Y Returns6.39%
ICICI Prudential MidCap Fund - Growth
3Y Returns18.33%
Sundaram Mid Cap Fund Regular Plan - Growth
3Y Returns22.14%